Literature DB >> 14739546

Regional cerebral blood flow in Alzheimer's disease: classification and analysis of heterogeneity.

Siegbert Warkentin1, Mattias Ohlsson, Per Wollmer, Lars Edenbrandt, Lennart Minthon.   

Abstract

Neural networks have been successfully applied to brain perfusion images to classify patients with Alzheimer's disease from normal or other patient populations. Given the recognition that Alzheimer's disease constitutes a heterogeneous disorder, the identification of subgroups sharing common functional brain deficits would constitute a further improvement in the utility of such methods. Therefore, we aimed to investigate whether neural networks could discriminate cortical perfusion deficits of patients with Alzheimer's disease from normal brain perfusion. A second step was to identify subgroups of patients sharing similar perfusion deficits. The study population consisted of one group of 92 normal healthy subjects and one group of 132 patients with mild-to-moderate Alzheimer's disease. The patients were diagnosed according to established criteria (DSM-IV and NINCDS-ADRDA). Regional cerebral blood flow was assessed by the non-invasive (133)Xe inhalation method, using a 64-detector system for measurements of blood flow in superficial cortical areas. The regional blood flow values were used as the only input to artificial neural networks with multilayer Perceptron architecture. The networks were trained using the back-propagation updating algorithm. A fourfold cross validation procedure was used in order to obtain the most reliable performance of the networks. The performance of the neural network, measured as the area under the receiver-operating characteristic curve, was 0.94, with a sensitivity for Alzheimer's disease of 86% at a specificity of 90%. An analysis of the relative importance of cortical areas in the discrimination showed that left parietal areas were more important than the right homologous ones. A clustering analysis of the Alzheimer patients identified three or four subgroups of patients with clearly different combinations of blood flow pathology. A consistent finding in all subgroups was a significant deficit in temporoparietal blood flow of both hemispheres. Distinct group differences were seen in frontal, central and occipital areas with different combinations of involvement. This is the first study in which neural networks have been applied to brain perfusion images obtained with the (133)Xe inhalation method. The results demonstrate that a classification of patients with Alzheimer's disease obtained with this method is compatible with the best results obtained with other brain imaging methods. The identification of clearly distinguishable patterns of blood flow pathology in subgroups of patients lends further support to the notion that Alzheimer's disease is a heterogeneous disorder. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14739546     DOI: 10.1159/000076358

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  8 in total

1.  Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease.

Authors:  Christian Habeck; Norman L Foster; Robert Perneczky; Alexander Kurz; Panagiotis Alexopoulos; Robert A Koeppe; Alexander Drzezga; Yaakov Stern
Journal:  Neuroimage       Date:  2008-02-14       Impact factor: 6.556

2.  Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson's disease by (123)I-FP-CIT brain SPECT.

Authors:  Barbara Palumbo; Mario Luca Fravolini; Susanna Nuvoli; Angela Spanu; Kai Stephan Paulus; Orazio Schillaci; Giuseppe Madeddu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-23       Impact factor: 9.236

3.  Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging.

Authors:  Duygu Tosun; Pouria Mojabi; Michael W Weiner; Norbert Schuff
Journal:  Neuroimage       Date:  2010-04-18       Impact factor: 6.556

4.  Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.

Authors:  Panagiotis Alexopoulos; Christian Sorg; Annette Förschler; Timo Grimmer; Maria Skokou; Afra Wohlschläger; Robert Perneczky; Claus Zimmer; Alexander Kurz; Christine Preibisch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-07-24       Impact factor: 5.270

5.  Regional Cerebral Blood Flow during Wakeful Rest in Older Subjects with Mild to Severe Obstructive Sleep Apnea.

Authors:  Andrée-Ann Baril; Katia Gagnon; Caroline Arbour; Jean-Paul Soucy; Jacques Montplaisir; Jean-François Gagnon; Nadia Gosselin
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

Review 6.  P2Y receptors in Alzheimer's disease.

Authors:  Laurie Erb; Chen Cao; Deepa Ajit; Gary A Weisman
Journal:  Biol Cell       Date:  2014-10-13       Impact factor: 4.458

Review 7.  Hypertension and cognitive function.

Authors:  Thomas Olabode Obisesan
Journal:  Clin Geriatr Med       Date:  2009-05       Impact factor: 3.076

8.  Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.

Authors:  Annie G Bryant; Mary K Manhard; David H Salat; Bruce R Rosen; Bradley T Hyman; Keith A Johnson; Susie Huang; Rachel E Bennett; Yi-Fen Yen
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.